Tom Cascino, MD (@tomcascinomd) 's Twitter Profile
Tom Cascino, MD

@tomcascinomd

HF/Tx @umichCVC & @UM_IHPI | #SSOM & @UCSF alum | Working to improve the lives of people with #HeartFailure & #PAH | Michigan Sports Fan

ID: 895270871643959296

calendar_today09-08-2017 13:09:43

215 Tweet

639 Followers

997 Following

Clyde Yancy, MD, MSc (@nmhheartdoc) 's Twitter Profile Photo

#AHA23 Pecha Kucha Heart Failure Session - best 7 min, 20 graphic presentation winner? Nosheen Reza, MD, MS #awesome 👏🏽👏🏽👏🏽 Stay tuned for encore presentation next year! #NewStandard

#AHA23 Pecha Kucha Heart Failure Session - best 7 min, 20 graphic presentation winner? <a href="/noshreza/">Nosheen Reza, MD, MS</a> #awesome 👏🏽👏🏽👏🏽
Stay tuned for encore presentation next year! #NewStandard
PR Assembly (@pr_assembly) 's Twitter Profile Photo

Really thorough presentation from Prof Carly Rochester on the new American Thoracic Society (ATS) PR Assembly #CPG with consideration of the evidence-based recommendations, unmet research needs and strategies for implementation. With thanks to the panel Surya P Bhatt, MD, MSPH Tom Cascino, MD Linzy Houchen-Wolloff 💻

Really thorough presentation from Prof Carly Rochester on the new <a href="/atscommunity/">American Thoracic Society (ATS)</a> <a href="/PR_Assembly/">PR Assembly</a> #CPG with consideration of the evidence-based recommendations, unmet research needs and strategies for implementation. With thanks to the panel <a href="/suryapbhatt/">Surya P Bhatt, MD, MSPH</a> <a href="/TomCascinoMD/">Tom Cascino, MD</a> <a href="/LinzyWolloff/">Linzy Houchen-Wolloff</a> 💻
Jason Weatherald MD (@albertaphdoc) 's Twitter Profile Photo

Couldn’t coordinate all of us, but here is most of our Task Force 11 getting ready for our session today. You will note that since we are a forward-looking group planning the next innovative clinical trials in PH, we are already in the future (2042) 😉 #WSPH2024 WSPH Association

Couldn’t coordinate all of us, but here is most of our Task Force 11 getting ready for our session today. You will note that since we are a forward-looking group planning the next innovative clinical trials in PH, we are already in the future (2042) 😉 #WSPH2024 <a href="/AssociationWsph/">WSPH Association</a>
Arika Lycan (they/them) 🏳️‍⚧️🏳️‍🌈 (@arikagrace) 's Twitter Profile Photo

We're very excited to welcome new #UMPrecisionHealth members to our community! We're shining a light on the following folks who've joined in the past month. Please help give them a warm welcome! Menggang Yu, Dr. Besa Xhabija, Tom Cascino, MD, Erin Kahle Anthony Rosenzweig, MD Toni Coe 🎉

We're very excited to welcome new #UMPrecisionHealth members to our community! We're shining a light on the following folks who've joined in the past month. Please help give them a warm welcome! <a href="/MenggangYu/">Menggang Yu</a>, <a href="/besaxhabija/">Dr. Besa Xhabija</a>, <a href="/TomCascinoMD/">Tom Cascino, MD</a>, Erin Kahle <a href="/rosenzweig_a/">Anthony Rosenzweig, MD</a> <a href="/antoinettebcoe/">Toni Coe</a> 🎉
Manreet Kanwar (@manreetkanwar) 's Twitter Profile Photo

LVADs should be considered as an option for net prolongation of life in young pts. Aditi Nayak Tom Cascino, MD Vanessa Blumer, MD, FACC Katherine Wood Stavros George Drakos Mark Belkin Ryan J Tedford MD STS Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients annalsthoracicsurgery.org/article/S0003-…

Vanessa Blumer, MD, FACC (@vbluml) 's Twitter Profile Photo

Should we be considering LVADs as an option for net prolongation of life in young pts? ⚖️ Manreet Kanwar Aditi Nayak Tom Cascino, MD Katherine Wood Palak Shah Iyad Isseh إياد نبيل العسّة Inova Schar Heart and Vascular 📌STS Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients annalsthoracicsurgery.org/article/S0003-…

Aditi Nayak (@aditinayakmd) 's Twitter Profile Photo

1/ 🔥Check out the latest #STS Intermacs annual report 👇🏽 We demonstrate ongoing excellent outcomes for #LVAD patients, AND much better outcomes for #BiVADs in the contemporary era, with a special 🔬on young patients (<50 years) annalsthoracicsurgery.org/article/S0003-…

JHLT (@thejhlt) 's Twitter Profile Photo

Despite evolving treatment options for #PAH, morbidity & mortality remain high. Sotatercept, a novel activin signaling inhibitor, shows promise. This review explores its mechanism, patient outcomes, and safety. Tom Cascino, MD 🔗: jhltonline.org/article/S1053-…

Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

Check out these highlights from the World Symposium on PH, curated specifically for the HF cardiologist 🌎🫀 From phenotyping PH-Left Heart Disease to considering how to incorporate sotatercept, this #JCF piece has you covered with the latest. 🔗 bit.ly/3BZDhjP

Check out these highlights from the World Symposium on PH, curated specifically for the HF cardiologist 🌎🫀  

From phenotyping PH-Left Heart Disease to considering how to incorporate sotatercept, this #JCF piece has you covered with the latest.

🔗 bit.ly/3BZDhjP
Kay Everett, MD, PhD (@kayeverettmdphd) 's Twitter Profile Photo

The GRS on Assisted Circulation is coming up soon! Check out the program 👉 grc.org/assisted-circu… 💡If you haven’t applied yet, there’s still time — the deadline is May 10. 🙏Reposts appreciated!

The GRS on Assisted Circulation is coming up soon! Check out the program 👉 grc.org/assisted-circu…
💡If you haven’t applied yet, there’s still time — the deadline is May 10. 
🙏Reposts appreciated!
The ISHLT (@ishlt) 's Twitter Profile Photo

#ISHLT appoints the first non-physician Scientific Program Chair for #ISHLT2027, Melissa Cousino, PhD. 🎉🫀🫁 "As the first transplant psychologist and allied health professional in this role, this highlights the ISHLT’s tremendous commitment to uplifting the multidisciplinary

#ISHLT appoints the first non-physician Scientific Program Chair for #ISHLT2027, Melissa Cousino, PhD. 🎉🫀🫁

"As the first transplant psychologist and allied health professional in this role, this highlights the ISHLT’s tremendous commitment to uplifting the multidisciplinary
PR Assembly (@pr_assembly) 's Twitter Profile Photo

With huge thanks to our expert panel of speakers PR Assembly for the symposium session A87:  Virtual Pulmonary Rehabilitation: A Pro/con debate. Key message: Virtual PR is an option for selected patients but it needs to be adequately prescribed and supervised. 💻 💪

With huge thanks to our expert panel of speakers <a href="/PR_Assembly/">PR Assembly</a> for the symposium session A87:  Virtual Pulmonary Rehabilitation: A Pro/con debate. 
Key message: Virtual PR is an option for selected patients but it needs to be adequately prescribed and supervised. 💻 💪